Provided by Tiger Trade Technology Pte. Ltd.

Odyssey Therapeutics

18.55
-0.1700-0.91%
Volume:397.74K
Turnover:7.32M
Market Cap:890.98M
PE:-6.00
High:18.92
Open:18.50
Low:17.55
Close:18.72
52wk High:20.30
52wk Low:15.35
Shares:48.03M
Float Shares:13.24M
Volume Ratio:0.63
T/O Rate:3.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0910
EPS(LYR):-5.1590
ROE:-85.50%
ROA:-41.66%
PB:-1.70
PE(LYR):-3.60

Loading ...

Company Profile

Company Name:
Odyssey Therapeutics
Exchange:
NASDAQ
Establishment Date:
2021
Employees:
100
Office Location:
51 Sleeper Street,Suite 800,Boston,Massachusetts,United States
Zip Code:
02210
Fax:
- -
Introduction:
- -

Directors

Name
Position
Gary D. Glick
Chief Executive Officer and Director and President
Carolyn Ng
Independent Director
Ian F. Smith
Independent Director
Jeffrey M. Leiden
Chair and Independent Director
Ksenija Pavletic
Independent Director
Nan Li
Independent Director
Nia Tatsis
Independent Director
Paulina Hill
Independent Director
Shelley Chu
Independent Director
Timothy P. Walbert
Independent Director
Valerie Odegard
Independent Director

Shareholders

Name
Position
Gary D. Glick
Chief Executive Officer and Director and President
Collin Todd
Senior Vice President, Strategy and Business Development
Jason Haas
Chief Financial Officer
Anthony Opipari
Executive Vice President, Translational Medicine and Interim Chief Medical Officer
Jolie M. Siegel
Executive Vice President and General Counsel and Secretary
Natalie Dales
Chief of Research Operations and Portfolio Strategy